Trademark applications and grants for Crystalgenomics Inc. Crystalgenomics Inc has 1 trademark applications. The latest application filed is for "ACELEX"
Patent Application | Date |
---|---|
PHARMACEUTICAL COMPOSITION COMPRISING HDAC INHIBITOR AND ANTI-PD1 ANTIBODY OR ANTI PD-L1 ANTIBODY 20220287993 - 17/637356 KIM; Young-Dae ;   et al. | 2022-09-15 |
INJECTION COMPOSITION CONTAINING FAB I INHIBITOR, AND PREPARATION METHOD THEREFOR 20220031607 - 17/296355 CHO; Jae Pyoung ;   et al. | 2022-02-03 |
ORALLY ADMINISTERED PHARMACEUTICAL COMPOSITION COMPRISING FAB I INHIBITORS AND METHOD FOR PREPARING SAME 20220016098 - 17/258954 CHO; Jae Pyoung ;   et al. | 2022-01-20 |
PHARMACEUTICAL COMPOSITION CONTAINING ALKYL CARBAMOYL NAPHTHALENYLOXY OCTENOYL HYDROXYAMIDE PHOSPHATE, TARTRATE OR COMBINATION THEREOF, AND PREPARATION METHOD THEREFOR 20210346321 - 17/283627 CHO; Jae Pyoung ;   et al. | 2021-11-11 |
PHARMACEUTICAL COMPOSITION, COMPRISING POLMACOXIB AND PREGABALIN, FOR TREATMENT OF PAIN 20210113515 - 16/982137 CHO; Jae Pyoung ;   et al. | 2021-04-22 |
Mark Image Registration | Serial | Trademark Application Date |
---|---|
"ACELEX" 79228525 |
ACELEX 2017-12-01 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.